Controversial obesity drug gets UK okay, Reuters reports here at Yahoo News: LONDON – Sanofi-Aventis won a final green light for its obesity drug Acomplia from Britain’s cost-effectiveness watchdog NICE on Wednesday, clearing the way for doctors to prescribe it on the state health service.
